MNPR
Monopar Therapeutics Inc.$71.85-0.69 (-0.96%)Prev Close$72.00·MCap$483.3M·P/E—·Vol183.5K·Yield—
▲
Buys (12M)
1
$104.9K
▼
Sells (12M)
10
$5.16M
◆
Net Activity
Net Seller
$5.06M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Monopar Therapeutics Inc. (MNPR) has been dominated by selling, with 1 insider purchase totaling $104.9K and 10 insider sales totaling $5.16M. The most recent insider transaction was by Tsuchimoto Kim R (director), who sold $290.1K worth of shares on Nov 4, 2026. Monopar Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $483.3M.
MNPR Insider Trading Activity
MNPR Insider Buying Activity
The following table shows recent insider purchases of Monopar Therapeutics Inc. (MNPR) stock reported via SEC Form 4 filings.
MNPR Insider Selling Activity
The following table shows recent insider sales of Monopar Therapeutics Inc. (MNPR) stock reported via SEC Form 4 filings.